NICE makes recommendations to the government-run National Health Service on the cost-effectiveness of drugs or medical devices. NHS, in turn, uses these recommendations to decide whether to pay for use of these instruments.
More Articles on Orthopedic Devices:
Conmed’s Arthroscopic Business Line Sees 15% Growth
CareFusion Reports $968M 4Q Revenue, Up 3%
8 Spine Device Company 2Q Financial Reports
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.